Summary
Lactulose is one of the most frequently utilised agents in the treatment of constipation and hepatic encephalopathy because of its efficacy and good safety profile. The key to understanding the possible modes of action by which lactulose achieves its therapeutic effects in these disorders lies in certain pharmacological phenomena: (a) lactulose is a synthetic disaccharide that does not occur naturally; (b) there is no disaccharidase on the microvillus membrane of enterocytes in the human small intestine that hydrolyses lactulose; and (c) lactulose is not absorbed from the small intestine. Thus, the primary site of action is the colon in which lactulose is readily fermented by the colonic bacterial flora with the production of short-chain fatty acids and various gases. The purpose of this review is to focus on some pertinent basic aspects of the clinical pharmacology of lactulose and to discuss the possible mechanisms by which lactulose benefits patients with constipation and hepatic encephalopathy.
Article PDF
Similar content being viewed by others
References
Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991; 70: 443–59
Carulli N, Salviolo GF, Manenti F. Absorption of lactulose in man. Digestion 1972; 6: 139–45
Saunders DR, Wiggins HS. Conservation of mannitol, lactulose, and raffinose by the human colon. Am J Physiol 1981; 241: G397–402
Zarling EJ, Ruchim MA. Protein origin of the volatile fatty acids isobutyrate and isovalerate in human stool. J Lab Clin Med 1987; 109: 566–70
Rasmussen HS, Holtug K, Mortensen PB. Degradation of amino acids to short chain fatty acids in humans: an in vitro study. Scand J Gastroenterol 1988; 23: 178–82
Florent C, Flourié B, Leblond A, et al. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest 1985; 75: 608–13
Hove H, Mortensen PB. Colonic lactate metabolism and D-lactate acidosis. Dig Dis Sci 1995; 40: 320–30
Bustos D, Pons S, Pernas JC, et al. Fecal lactate and short bowel syndrome. Dig Dis Sci 1994; 39: 2315–9
Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221–7
Mortensen PB, Hove H, Clausen MR, et al. Fermentation to short-chain fatty acids and lactate in human faecal batch cultures. Intra-and inter-individual variations versus variations caused by changes in fermented saccharides. Scand J Gastroenterol 1991; 26: 1285–94
McNeil NI, Cummings JH, James WPT. Short chain fatty acid absorption by the human large intestine. Gut 1978; 19: 819–22
Ruppin H, Bar-Meir S, Soergel KH, et al. Absorption of short-chain fatty acids by the colon. Gastroenterology 1980; 78: 1500–7
Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonie mucosa in man. Gut 1980; 21: 793–8
Clausen MR, Mortensen PB. Kinetic studies on the metabolism of short-chain fatty acids and glucose by isolated rat colonocytes. Gastroenterology 1994; 106: 423–32
Clausen MR, Mortensen PB. Kinetic studies on colonocyte metabolism of short-chain fatty acids and glucose in ulcerative colitis. Gut 1995; 37: 684–9
McNeil NI. The contribution of the large intestine to energy supplies in man. Am J Clin Nutr 1984; 39: 338–42
Vince A, Killingley M, Wrong OM. Effect of lactulose on ammonia production in a fecal incubation system. Gastroenterology 1978; 74: 544–9
Mortensen PB, Holtug K, Rasmussen HS. Short-chain fatty acid production from mono-and disaccharides in a fecal incubation system: implications for colonie fermentation of dietary fiber in humans. J Nutr 1988; 118: 321–5
Mortensen PB, Rasmussen HS, Holtug K. Lactulose detoxifies in vitro short-chain fatty acid production in colonie contents induced by blood: implications for hepatic coma. Gastroenterology 1988; 94: 750–4
Peters SG, Pomare EW, Fisher CA. Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut 1992; 33: 1249–52
Bond JH, Levitt MD. Use of pulmonary hydrogen measurements to quantitate carbohydrate absorption: study of partially gastrectomized patients. J Clin Invest 1972; 51: 1219–25
Strocchi A, Corazza G, Ellis CJ, et al. Detection of malabsorption of low doses of carbohydrates: accuracy of various breath H2 criteria. Gastroenterology 1993; 105: 1404–10
Bown RL, Gibson JA, Sladen GE, et al. Effects of lactulose and other laxatives on ileal and colonie pH as measured by a radiotelemetry device. Gut 1974; 15: 999–1004
Bircher J, Müller J, Guggenheim P, et al. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet 1966; I: 890–3
Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind controlled trial. Gastroenterology 1977; 72: 573–83
Holtug K, Clausen MR, Hove H, et al. The colon in carbohydrate malabsorption: short-chain fatty acids, pH, and osmotic diarrhoea. Scand J Gastroenterol 1992; 27: 545–52
Conn HO, Floch MH. Effects of lactulose and lactobacillus acidophilus on the fecal flora. Am J Clin Nutr 1970; 23: 1588–94
Vince A, Zeegen R, Drinkwater JE, et al. The effect of lactulose on the faecal flora of patients with hepatic encephalopathy. J Med Microbiol 1974; 7: 163–8
Riggio O, Varriale M, Testore GP, et al. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients. J Clin Gastroenterol 1990; 12: 433–6
Flourié B, Briet F, Florent C, et al. Can diarrhea induced by lactulose be reduced by prolonged ingestion of lactulose? Am J Clin Nutr 1993; 58: 369–75
Stephen AM, Cummings JH. Mechanism of action of dietary fibre in the human colon. Nature 1980; 284: 283–4
Weber FL. The effect of lactulose on urea metabolism and nitrogen excretion in cirrhotic patients. Gastroenterology 1979; 77: 518–23
Mortensen PB. The effect of oral-administered lactulose on co-Ionic nitrogen metabolism and excretion. Hepatology 1992; 16: 1350–6
Kot TV, Pettit-Young NA. Lactulose in the management of constipation: a current review. Ann Pharmacother 1992; 26: 1277–82
Weijers HA, van de Kamer JH, Dicke WK, et al. Diarrhoea caused by deficiency of sugar splitting enzymes. Acta Paediatr 1961; 50: 55–71
Haemmerli UP, Kistler H, Ammann R, et al. Acquired milk intolerance in the adult caused by lactose malabsorption due to a selective deficiency of intestinal lactase activity. Am J Med 1965; 38: 7–30
Bustos Fernández L, Gonzalez E, Marzi A, et al. Fecal acidorrhea. N Engl J Med 1971; 284: 295–8
Christopher NL, Bayless TM. Role of the small bowel and colon in lactose-induced diarrhea. Gastroenterology 1971; 60: 845–52
Hammer HF, Santa Ana CA, Schiller LR, et al. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest 1989; 84: 1056–62
Argenzio RA, Moon HW, Kemeny LJ, et al. Colonic compensation in transmissible gastroenteritis of swine. Gastroenterology 1984; 86: 1501–9
Launiala K. The mechanism of diarrhoea in congenital disaccharide malabsorption. Acta Paediat Scand 1968; 57: 425–32
Perman JA, Modler S, Olson AC. Role of pH in production of hydrogen from carbohydrates by colonic bacterial flora: studies in vivo and in vitro. J Clin Invest 1981; 67: 643–50
Mortensen PB, Holtug K, Bonnén H, et al. The degradation of amino acids, proteins, and blood to short-chain fatty acids in colon is prevented by lactulose. Gastroenterology 1990; 98: 353–60
Phillips SF, Giller J. The contribution of the colon to electrolyte and water conservation in man. J Lab Clin Med 1973; 81: 733–46
Bond JH, Levitt MD. Quantitative measurement of lactose absorption. Gastroenterology 1976; 70: 1058–62
Debongnie JC, Phillips SF. Capacity of the human colon to absorb fluid. Gastroenterology 1978; 74: 698–703
Chauve A, Devroede G, Bastin E. Intraluminal pressures during perfusion of the human colon in situ. Gastroenterology 1976; 70: 336–40
Zieve L. The mechanism of hepatic coma. Hepatology 1981; 1: 360–5
Vince A, Down PF, Murison J, et al. Generation of ammonia from non-urea sources in a faecal incubation system. Clin Sci Mol Med 1976; 51: 313–22
Haemmerli UP, Bircher J. Wrong idea, good results. (The lactulose story.) N Engl J Med 1969; 281: 441–2
Zeegen R, Drinkwater JE, Fenton JCB, et al. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy. Q J Med 1970; 39: 245–63
Agostini L, Down PF, Murison J, et al. Faecal ammonia and pH during lactulose administration in man: comparison with other cathartics. Gut 1972; 13: 859–66
Weber FL, Banwell JG, Fresard KM, et al. Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycin. J Lab Clin Med 1987; 110: 259–63
Samson FE, Dahl N, Dahl DR. A study on the narcotic action of the short chain fatty acids. J Clin Invest 1956; 35: 1291–8
White RP, Samson FE. Effects of fatty acid anions on the electroencephalogram of unanesthetized rabbits. Am J Physiol 1956; 186: 271–4
Oldendorf WH. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 1973; 224: 1450–3
Linscheer WG, Blum AL, Platt RR. Transfer of medium chain fatty acids from blood to spinal fluid in patients with cirrhosis. Gastroenterology 1970; 58: 509–15
Dahl DR. Short chain fatty acid inhibition of rat brain Na-K adenosine triphosphatase. J Neurochem 1968; 15: 815–20
Trauner DA. Regional cerebral Na+K+ ATPase activity following octanoate administration. Pediatr Res 1980; 14: 844–5
Muto Y, Takahashi Y. Gas Chromatographie determination of plasma short chain fatty acids in diseases of the liver. J Jpn Soc Int Med 1964; 53: 82839. Cited in Postgrad Med 1965; 37: A158
Lai JCK, Silk DBA, Williams R. Plasma short-chain fatty acids in fulminant hepatic failure. Clin Chim Acta 1977; 78: 305–10
Clausen MR, Mortensen PB, Bendtsen F. Serum levels of short-chain fatty acids in cirrhosis and hepatic coma. Hepatology 1991; 14: 1040–5
Hommes FA, Kuipers JRG, Elema JD, et al. Propionicacidemia, a new inborn error of metabolism. Pediatr Res 1968; 2: 519–24
Branski D, Gale R, Gross-Kieselstein E, et al. Propionic acidemia and anorectal anomalies in three siblings. Am J Dis Child 1977; 131: 1379–81
Hillman RE. Simple, rapid method for determination of propionic acid and other short-chain fatty acids in serum. Clin Chem 1978; 24: 800–3
Budd MA, Tanaka K, Holmes LB, et al. Isovaleric acidemia: clinical features of a new genetic defect of leucine metabolism. N Engl J Med 1967; 277: 321–7
Duran M, Sprang FJ van, Drewes JG, et al. Two sisters with isovaleric acidaemia, multiple attacks of ketoacidosis and normal development. Eur J Pediatr 1979; 131: 205–11
Scheppach W, Richter F, Joeres R, et al. Systemic availability of propionate and acetate in liver cirrhosis. Am J Gastroenterol 1988; 83: 850–3
Linscheer W, Castell DO, Platt RR. A new method for evaluation of portosystemic shunting. Gastroenterology 1969; 57: 415–23
Zieve FJ, Zieve L, Doizaki WM, et al. Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma. J Pharmacol Exp Ther 1974; 191: 10–6
Zieve L, Doizaki WM, Zieve FJ. Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 1974; 83: 16–28
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clausen, M.R., Mortensen, P.B. Lactulose, Disaccharides and Colonic Flora. Drugs 53, 930–942 (1997). https://doi.org/10.2165/00003495-199753060-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199753060-00003